NCT01736891View on ClinicalTrials.gov

Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations

PHASE3CompletedINTERVENTIONAL
Enrollment

268

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Parkinson´s Disease
Interventions
DRUG

Rasagiline

Tablets, qd

DRUG

Placebo

Tablets, qd

Trial Locations (8)

210029

CN008, Nanjing

404000

CN007, Chongqing

423000

CN005, Chenzhou

541001

CN003, Guilin

610041

CN002, Chengdu

646000

CN006, Luzhou

710032

CN001, Xi'an

730050

CN004, Lanzhou

Sponsors
All Listed Sponsors
collaborator

Beijing Bionovo Medicine Development Co., Ltd.

OTHER

lead

Chongqing Fortune Pharmaceutical Co., Ltd.

INDUSTRY